ALPMY
Price
$9.60
Change
-$0.05 (-0.52%)
Updated
Jul 3 closing price
Capitalization
26.55B
25 days until earnings call
BAYRY
Price
$7.67
Change
-$0.11 (-1.41%)
Updated
Jul 3 closing price
Capitalization
57.55B
32 days until earnings call
Interact to see
Advertisement

ALPMY vs BAYRY

Header iconALPMY vs BAYRY Comparison
Open Charts ALPMY vs BAYRYBanner chart's image
Astellas Pharma
Price$9.60
Change-$0.05 (-0.52%)
Volume$41.05K
Capitalization26.55B
Bayer A.G
Price$7.67
Change-$0.11 (-1.41%)
Volume$369.18K
Capitalization57.55B
ALPMY vs BAYRY Comparison Chart in %
Loading...
ALPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BAYRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALPMY vs. BAYRY commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALPMY is a Hold and BAYRY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (ALPMY: $9.60 vs. BAYRY: $7.67)
Brand notoriety: ALPMY and BAYRY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ALPMY: 31% vs. BAYRY: 51%
Market capitalization -- ALPMY: $26.55B vs. BAYRY: $57.55B
ALPMY [@Pharmaceuticals: Major] is valued at $26.55B. BAYRY’s [@Pharmaceuticals: Major] market capitalization is $57.55B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALPMY’s FA Score shows that 1 FA rating(s) are green whileBAYRY’s FA Score has 0 green FA rating(s).

  • ALPMY’s FA Score: 1 green, 4 red.
  • BAYRY’s FA Score: 0 green, 5 red.
According to our system of comparison, ALPMY is a better buy in the long-term than BAYRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALPMY’s TA Score shows that 5 TA indicator(s) are bullish while BAYRY’s TA Score has 4 bullish TA indicator(s).

  • ALPMY’s TA Score: 5 bullish, 5 bearish.
  • BAYRY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ALPMY is a better buy in the short-term than BAYRY.

Price Growth

ALPMY (@Pharmaceuticals: Major) experienced а +0.42% price change this week, while BAYRY (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.19%. For the same industry, the average monthly price growth was +2.56%, and the average quarterly price growth was +9.33%.

Reported Earning Dates

ALPMY is expected to report earnings on Jul 30, 2025.

BAYRY is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+1.19% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BAYRY($57.5B) has a higher market cap than ALPMY($26.6B). ALPMY has higher P/E ratio than BAYRY: ALPMY (37.59) vs BAYRY (17.04). BAYRY YTD gains are higher at: 57.921 vs. ALPMY (-0.621). ALPMY has higher annual earnings (EBITDA): 247B vs. BAYRY (12.1B). ALPMY has more cash in the bank: 397B vs. BAYRY (7.98B). ALPMY has higher revenues than BAYRY: ALPMY (1.52T) vs BAYRY (50.5B).
ALPMYBAYRYALPMY / BAYRY
Capitalization26.6B57.5B46%
EBITDA247B12.1B2,041%
Gain YTD-0.62157.921-1%
P/E Ratio37.5917.04221%
Revenue1.52T50.5B3,008%
Total Cash397B7.98B4,978%
Total Debt30BN/A-
FUNDAMENTALS RATINGS
ALPMY vs BAYRY: Fundamental Ratings
ALPMY
BAYRY
OUTLOOK RATING
1..100
5079
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
70
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10093
PRICE GROWTH RATING
1..100
6040
P/E GROWTH RATING
1..100
9889
SEASONALITY SCORE
1..100
4n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALPMY's Valuation (4) in the null industry is significantly better than the same rating for BAYRY (70). This means that ALPMY’s stock grew significantly faster than BAYRY’s over the last 12 months.

ALPMY's Profit vs Risk Rating (100) in the null industry is in the same range as BAYRY (100). This means that ALPMY’s stock grew similarly to BAYRY’s over the last 12 months.

BAYRY's SMR Rating (93) in the null industry is in the same range as ALPMY (100). This means that BAYRY’s stock grew similarly to ALPMY’s over the last 12 months.

BAYRY's Price Growth Rating (40) in the null industry is in the same range as ALPMY (60). This means that BAYRY’s stock grew similarly to ALPMY’s over the last 12 months.

BAYRY's P/E Growth Rating (89) in the null industry is in the same range as ALPMY (98). This means that BAYRY’s stock grew similarly to ALPMY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALPMYBAYRY
RSI
ODDS (%)
Bullish Trend 3 days ago
60%
Bearish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
63%
Bullish Trend 3 days ago
59%
Momentum
ODDS (%)
Bullish Trend 3 days ago
63%
Bearish Trend 3 days ago
65%
MACD
ODDS (%)
Bullish Trend 3 days ago
48%
Bearish Trend 3 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
60%
Bullish Trend 3 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
70%
Bullish Trend 3 days ago
62%
Advances
ODDS (%)
Bullish Trend 6 days ago
63%
Bullish Trend 9 days ago
59%
Declines
ODDS (%)
Bearish Trend 16 days ago
68%
Bearish Trend 3 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
61%
Bearish Trend 3 days ago
67%
Aroon
ODDS (%)
Bearish Trend 3 days ago
68%
Bullish Trend 3 days ago
55%
View a ticker or compare two or three
Interact to see
Advertisement
ALPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BAYRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UGRO0.310.01
+3.23%
urban-gro
CFFI67.272.08
+3.19%
C&F Financial Corp
UTI32.300.70
+2.22%
Universal Technical Institute
IX22.890.07
+0.31%
Orix Corp
BTG3.66N/A
N/A
B2Gold Corp

ALPMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALPMY has been loosely correlated with ALPMF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ALPMY jumps, then ALPMF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALPMY
1D Price
Change %
ALPMY100%
-0.52%
ALPMF - ALPMY
37%
Loosely correlated
N/A
OPHLY - ALPMY
32%
Poorly correlated
-0.85%
OTSKY - ALPMY
21%
Poorly correlated
-1.50%
BAYRY - ALPMY
13%
Poorly correlated
-1.16%
ABBV - ALPMY
12%
Poorly correlated
-0.77%
More

BAYRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAYRY has been closely correlated with BAYZF. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if BAYRY jumps, then BAYZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAYRY
1D Price
Change %
BAYRY100%
-1.16%
BAYZF - BAYRY
88%
Closely correlated
-0.90%
OPHLY - BAYRY
23%
Poorly correlated
-0.85%
AZNCF - BAYRY
20%
Poorly correlated
-2.22%
CSPCY - BAYRY
20%
Poorly correlated
+4.50%
ALPMY - BAYRY
13%
Poorly correlated
-0.52%
More